CORRADINI, Elena
 Distribuzione geografica
Continente #
NA - Nord America 6.582
EU - Europa 4.021
AS - Asia 1.489
SA - Sud America 143
AF - Africa 15
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 3
Totale 12.264
Nazione #
US - Stati Uniti d'America 6.546
IT - Italia 1.233
GB - Regno Unito 1.228
SG - Singapore 547
SE - Svezia 416
CN - Cina 392
HK - Hong Kong 303
DE - Germania 263
RU - Federazione Russa 178
UA - Ucraina 167
FI - Finlandia 130
BR - Brasile 127
FR - Francia 113
TR - Turchia 79
BG - Bulgaria 62
NL - Olanda 55
ID - Indonesia 50
LT - Lituania 36
CA - Canada 30
IE - Irlanda 26
AT - Austria 23
IN - India 20
RO - Romania 19
BE - Belgio 18
KR - Corea 18
VN - Vietnam 16
CH - Svizzera 15
MY - Malesia 14
JP - Giappone 10
AU - Australia 9
PK - Pakistan 8
ZA - Sudafrica 8
AR - Argentina 7
ES - Italia 6
PT - Portogallo 6
IL - Israele 5
IR - Iran 5
CZ - Repubblica Ceca 4
MA - Marocco 4
CL - Cile 3
GR - Grecia 3
HU - Ungheria 3
LU - Lussemburgo 3
PH - Filippine 3
AL - Albania 2
AZ - Azerbaigian 2
BD - Bangladesh 2
BY - Bielorussia 2
CO - Colombia 2
DK - Danimarca 2
JM - Giamaica 2
LA - Repubblica Popolare Democratica del Laos 2
NZ - Nuova Zelanda 2
PL - Polonia 2
PS - Palestinian Territory 2
SI - Slovenia 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
CR - Costa Rica 1
EU - Europa 1
GA - Gabon 1
IQ - Iraq 1
JO - Giordania 1
KE - Kenya 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
MX - Messico 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PY - Paraguay 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 12.264
Città #
Santa Clara 981
Fairfield 869
Southend 821
Woodbridge 489
Chandler 485
Ashburn 427
Houston 401
Singapore 354
London 307
Hong Kong 302
Seattle 284
Cambridge 277
Jacksonville 257
Nyköping 255
Wilmington 248
Ann Arbor 209
Dearborn 208
Modena 194
San Diego 100
Beijing 98
Helsinki 83
Milan 81
Bologna 75
Chicago 75
Princeton 69
Sofia 61
Moscow 59
Izmir 54
Eugene 49
Parma 47
Jakarta 46
New York 44
Redwood City 43
Council Bluffs 40
Hefei 37
Bremen 36
Los Angeles 35
Rome 35
Shanghai 33
Reggio Emilia 24
Des Moines 23
Florence 21
Nuremberg 19
Amsterdam 18
Borzano 18
Dallas 18
Dublin 18
Bari 17
Formigine 16
Munich 15
Brussels 14
Dong Ket 14
Rimini 13
Kassel 12
Kilburn 12
Lappeenranta 12
Norwalk 12
Padova 12
Trento 12
Vienna 12
Ottawa 11
Reggio Nell'emilia 11
The Dalles 11
Timisoara 11
Frankfurt am Main 10
Frattamaggiore 10
Quartu Sant'Elena 10
Toronto 10
Boardman 9
Carpi 9
Falls Church 9
Kunming 9
Lauterbourg 9
Seongnam 9
Verona 9
Chiswick 8
Guangzhou 8
Portici 8
San Giuliano Milanese 8
Treviso 8
Abano Terme 7
Durban 7
Nanjing 7
Paris 7
Phoenix 7
Rio de Janeiro 7
Saint Petersburg 7
São Paulo 7
Auburn Hills 6
Bobbio 6
Roncoferraro 6
Fremont 5
Jinan 5
Lugo 5
Naples 5
New Delhi 5
North Bergen 5
Philadelphia 5
San Mateo 5
Tulare 5
Totale 9.206
Nome #
Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis 314
Clinical and molecular epidemiology of erythropoietic protoporphyria in Italy 296
Non-HFE Hepatic Iron Overload. 286
Iron overload in Africans and African-Americans and a common mutation in the SCL40A1 (ferroportin 1) gene 279
Gluconeogenic Signals Regulate Iron Homeostasis via Hepcidin in Mice. 267
Clinical impact of application of risk assessment models (Padua Prediction Score and Improve Bleeding Score) on venous thromboembolism, major hemorrhage and health expenditure associated with pharmacologic VTE prophylaxis: a “real life” prospective and retrospective observational study on patients hospitalized in a Single Internal Medicine Unit (the STIME study) 254
Capitolo 31 "Malattia di Wilson ed emocromatosi", in Sezione V "Malattie del fegato" 250
Subacute copper-deficiency myelopathy in a patient with occult celiac disease 244
Ceruloplasmin gene variants are associated with hyperferritinemia and increased liver iron in patients with {NAFLD} 243
Regulation of TMPRSS6 by BMP6 and iron in human cells and mice. 239
Serum and Liver Iron Differently Regulate the Bone Morphogenetic Protein 6 (BMP6)-SMAD Signaling Pathway in Mice 236
Hepcidin expression does not rescue the iron-poor phenotype of Kupffer cells in Hfe-null mice after liver transplantation. 230
BMP-6 is a Key Endogenous Regulator of Hepcidin Expression and Iron Metabolism 229
Bone Morphogenetic Protein Signaling Is Impaired in an Hfe Knockout Mouse Model of Hemochromatosis. 226
Iron Regulation of Hepcidin Despite Attenuated Smad1,5,8 Signaling in Mice Without Transferrin Receptor 2 or Hfe. 220
A PAIR OF BROTHERS WITH ACERULOPLASMINEMIA DUE TO A NOVEL NONSENSE MUTATION: UNUSUAL PHENOTYPE AND EFFECTIVENESS OF IRON-CHELATION THERAPY BY DEFERASIROX 216
Juvenile hemochromatosis associated with pathogenic mutations of adult hemochromatosis genes 215
Kupffer cells and macrophages are not required for hepatic hepcidin activation during iron overload 207
THE MOLECULAR BASIS FOR THE HEPATIC REGULATION OF HEPCIDIN, THE IRON HORMONE, BY BONE MORPHOGENETIC PROTEINS. 203
Hepatitis B virus DNA integration in tumour tissue of a non-cirrhotic HFE-haemochromatosis patient with hepatocellular carcinoma. 199
Magnetic resonance imaging to identify classic and nonclassic forms of ferroportin disease 199
Altered hepatic BMP signaling pathway in human HFE hemochromatosis. 198
First and second wave among hospitalized COVID-19 patients with severe pneumonia: a comparison of 28-day mortality over 1-year pandemic in a tertiary university hospital in Italy. 197
BMP6 treatment compensates for the molecular defect and ameliorates hemochromatosis in Hfe knockout mice. 193
Platelet count does not predict bleeding in cirrhotic patients: Results from the PRO-LIVER Study 193
Serum ferritin as a predictor of treatment outcome in patients with chronic hepatitis C 192
Iron and steatohepatitis. 189
null 186
Parametri predittivi e risposta sostenuta alla terapia antivirale combinata nell'epatite cronica attivva HCV correlata (ECA HCV) 183
Lack of enterocyte iron accumulation in the ferroportin disease 181
The RGM/DRAGON family of BMP co-receptors. 179
Disease progression and liver cancer in the ferroportin disease 174
Hereditary hemochromatosis. 167
Hyperhomocysteinemia in patients with acute porphyrias: A potentially dangerous metabolic crossroad? 166
Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: results from the SIMI-COVID-19 study of the Italian Society of Internal Medicine (SIMI) 163
SEX HORMONES DIFFERENTLY REGULATE HEPCIDIN EXPRESSION AND IRON HOMEOSTASIS IN VIVO. 161
Capitolo 8 "Epatopatie da accumulo: malattia di Wilson ed emocromatosi", in Sezione I "Epatiti acute e croniche" 161
Evaluating the association of serum ferritin and hepatic iron with disease severity in non-alcoholic fatty liver disease 161
A Pair of Brothers with Aceruloplasminemia Due To A Novel Nonsense Mutation: Unusual Phenotype And Neurological Improvement After Iron-Chelation Therapy With Deferasirox 159
GLUCONEOGENIC SIGNALS DIRECTLY CONTROL IRON HOMEOSTASIS THROUGH HEPCIDIN 157
Hereditary Haemochromatosis: the genes and the disease. 157
Fifty meanings of grey 154
Hereditary Hemochromatosis 151
Impact of natural neuromedin-B receptor variants on iron metabolism 148
Prolonged higher dose methylprednisolone vs. conventional dexamethasone in COVID-19 pneumonia: a randomised controlled trial (MEDEAS) 146
Prevalence of Gastrointestinal Symptoms in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Results of the Prospective Controlled Multinational GI-COVID-19 Study 142
Molecular and clinical correlates in iron overload associated with mutations in ferroportin 140
Hyperferritinemia and diagnosis of type 1 Gaucher disease 134
Can Disruption of Basal Ganglia-Thalamocortical Circuit in Wilson Disease Be Associated with Juvenile Myoclonic Epilepsy Phenotype? 130
Fortune favours the bold: finding the right route in the anemia's sea 127
Idiopathic brain calcification in a patient with hereditary hemochromatosis 127
Metodologia per l’adozione di linee guida cliniche in Medicina Interna. 126
Fegato, pancreas e vie biliari. 123
Clinical risk scores for the early prediction of severe outcomes in patients hospitalized for COVID-19 106
Iron and the liver 105
Clinical application of NGS in the diagnosis of iron overload disorders or hyperferritinemia of genetic origin 100
Haemochromatosis 96
Iron in Porphyrias: Friend or Foe? 95
Assistenza sanitaria primaria. Vol. 2: La formazione medica per il suo sviluppo 94
Juvenile hemocromatosis associated with pathogenetic mutations of adult hemocromatosis genes 93
Genetic iron overload disorders 93
Iron overload disorders 92
Assistenza sanitaria primaria. Aspetti culturali, metodi e strumenti per il suo sviluppo 85
Iron Metabolism in the Disorders of Heme Biosynthesis 78
Consensus Statement on the definition and classification of metabolic hyperferritinaemia 78
04092 Liver function, iron status, and hemopoiesis in erythropoietic protoporphyria (EPP): insights into a complex interplay 77
Do all critically ill patients with COVID-19 disease benefit from adding tocilizumab to glucocorticoids? A retrospective cohort study. 75
Labile plasma iron and echocardiographic parameters are associated to cardiac events in beta-thalassemic patients 75
CREB-H is a stress-regulator of hepcidin gene expression during early postnatal development 73
04093 Portal hypertension in advanced protoporphyric hepatopathy: a case report 73
A small molecule redistributes iron in ferroportin-deficient mice and patient-derived primary macrophages 72
Post COVID-19 irritable bowel syndrome 70
EASL Clinical Practice Guidelines on haemochromatosis 67
Use of digital technologies to support cancer screening in community health promotion interventions: scoping review 60
Reply to: “Ceruloplasmin variants might have different effects in different iron overload disorders” 59
A Population-based and Clinical Cohort Validation of the Novel Consensus Definition of Metabolic Hyperferritinemia 57
Erratum: Iron overload in Africans and African-Americans and a common mutation in the SCL40A1 (ferroportin 1) gene (Blood Cells, Molecules, and Diseases (2003) 31 (299-304) DOI: 10.1016/S1079-9796(03)00164-5) 56
Role and challenges to digital technologies in community health promotion programs in Italy during the COVID-19 pandemic: a multiple embedded case study protocol 51
Prevalence and Characteristics of Metabolic Hyperferritinemia in a Population-Based Central-European Cohort 46
Author Correction: Consensus Statement on the definition and classification of metabolic hyperferritinaemia (Nature Reviews Endocrinology, (2023), 19, 5, (299-310), 10.1038/s41574-023-00807-6) 44
SEX HORMONES DIFFERENTLY REGULATE HEPATIC HEPCIDIN EXPRESSION AND SYSTEMIC IRON HOMEOSTASIS IN VIVO 36
Developing an integrated care pathway to connect home-based palliative care and emergency departments: participatory action research on a quality improvement project 35
Haemochromatosis in children: A national retrospective cohort promoted by the A.I.E.O.P. (Associazione Italiana Emato-Oncologia Pediatrica) study group 33
Corrigendum to “EASL Clinical Practice Guidelines on haemochromatosis” [J Hepatol 2022 (77) 479–502](S0168827822002112)(10.1016/j.jhep.2022.03.033) 31
STAT3 is required for IL-6-gp130-dependent activation of hepcidin in vivo 2
Totale 12.424
Categoria #
all - tutte 57.624
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.624


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020174 0 0 0 0 0 0 0 0 0 0 99 75
2020/20211.882 119 65 105 127 215 200 193 303 77 160 137 181
2021/20221.503 90 127 179 58 82 65 111 104 196 107 216 168
2022/20231.571 153 165 110 137 197 208 44 177 186 39 90 65
2023/20241.179 59 68 128 118 152 83 96 159 35 83 101 97
2024/20253.076 165 48 100 255 757 593 222 223 459 193 61 0
Totale 12.424